In 2022, many new therapies and tests for cancer were approved, but a significant number of patients are still not receiving appropriate therapies. Suboptimal testing paradigms, reimbursement issues and physicians’ inability to keep up with rapidly advancing...
Myriad Genetics is set to share information about guarded BRCA variants in a public database, marking a significant shift in the company’s approach to sharing genetic information. Previously, the company had been criticized for guarding such information and...
Ellen Matloff sits down with Everyday Health to discuss the past, present, and future of genetic testing. With advances in technology and research, genetic testing is becoming increasingly accessible and informative. However, there are still many misconceptions and...
Newborn screening is a program in the US that tests newborn babies for various conditions that could affect their long-term health or survival. This testing has been lifesaving for many babies and families. However, there are concerns that states may keep the newborn...
BRCA-Related Breast and/or Ovarian Cancer syndrome is a hereditary cancer syndrome caused by mutations in the BRCA1 and BRCA2 genes. It results in increased risk for breast, ovarian, prostate, and pancreatic cancers and possibly melanoma. Experts believe genetic risk...
